Randall Schatzman - Articles and news items

Bristol Myers Squibb logo

Promising phase IIb data on Clazakizumab in patients with moderate-to-severe rheumatoid arthritis to be presented

Industry news / 28 October 2013 / Bristol-Myers Squibb Company

Clazakizumab is a humanized anti-IL-6 monoclonal antibody directed against the IL-6 cytokine rather than the receptor…

Bristol Myers Squibb logo

Promising phase IIb data on Clazakizumab in patients with moderate-to-severe Rheumatoid Arthritis to be presented

Industry news / 28 October 2013 / Bristol-Myers Squibb Company

Clazakizumab is a humanized anti-IL-6 monoclonal antibody that is directed against the IL-6 cytokine…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+